Position in BIIB
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$838,096
+$287,557 QoQ
Shares Held
3,879
+29.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#482
of 1,031 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sivia Capital Partners, LLC holds $16,248,994 across 14 Drug Manufacturers - General names. BIIB ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,555 | $4,263,974 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
47,373 | $2,729,632 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,440 | $2,112,540 | |
| 4 | PFE |
Pfizer Inc
|
82,650 | $1,990,212 | |
| 5 | NVS |
Novartis AG
|
6,151 | $963,984 | |
| 6 | JNJ |
Johnson & Johnson
|
3,459 | $878,482 | |
| 7 | BIIB |
Biogen Inc.
This page
|
3,879 | $838,096 | |
| 8 | GSK |
GSK plc
|
10,340 | $542,022 |
All Filings in BIIB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $838,096 | 3,879 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $550,539 | 3,003 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $407,416 | 2,315 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $321,903 | 2,298 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $215,638 | 1,717 | Shares | Sole | 2025-09-24 | |
| No filing history on record for this holder in this stock. | ||||||